CHINA GEWANG BIOTECHNOLOGY, INC.: 10-Q filed 2016-10-14
What CHINA GEWANG BIOTECHNOLOGY, INC. reported in its quarterly report filed 2016-10-14 (fiscal Q3 2016): 27 published measures, 70 facts as tagged in accession 0001511164-16-001076.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-10-14
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001511164-16-001076 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CHINA GEWANG BIOTECHNOLOGY, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 31,906,440 | USD | |
| At 2015-11-30 | 9,360,909 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 26,002,179 | USD | |
| At 2015-11-30 | 8,955,564 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-05-31 | 9,785,095 | USD | |
| At 2015-11-30 | 8,669,034 | USD | |
| At 2015-05-31 | 8,256,492 | USD | |
| At 2014-11-30 | 3,012,812 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | 7,380,031 | USD | 183 |
| 2014-12-01 to 2015-05-31 | 995,956 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | -6,992,656 | USD | 183 |
| 2014-12-01 to 2015-05-31 | 540,235 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 18,588,296 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 25,243,577 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 1,066,381 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 3,072,993 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | 9,848,200 | USD | 183 |
| 2014-12-01 to 2015-05-31 | 5,056,415 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | -1,097,897 | USD | 183 |
| 2014-12-01 to 2015-05-31 | -34,991 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 8,906,176 | USD | |
| At 2015-11-30 | 2,270,416 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 1,230,889 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 1,770,858 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 100,544 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 338,154 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 117,459 | USD | |
| At 2015-11-30 | 65,860 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 4,886,501 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 6,994,261 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 383,268 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 1,325,923 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 28,178,688 | USD | |
| At 2015-11-30 | 9,295,049 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 5,904,261 | USD | |
| At 2015-11-30 | 405,345 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 2,550,893 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 3,730,805 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 332,625 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 849,524 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 122,062 | USD | |
| At 2015-11-30 | 156,778 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 7,437,394 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 10,725,066 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 715,893 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 2,175,447 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 75,000,000 | shares | |
| At 2015-11-30 | 45,500,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 16,980,102 | USD | |
| At 2015-11-30 | 6,525,743 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | -120,886 | USD | |
| At 2015-11-30 | -85,523 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 32,913 | USD | |
| At 2015-11-30 | 33,375 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 5,391,389 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 7,380,031 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 287,040 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 995,956 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 235,273 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 495,212 | USD | 275 |
| 2015-06-01 to 2015-08-31 | 120,383 | USD | 92 |
| 2014-12-01 to 2015-08-31 | 308,637 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | 39,616 | USD | 183 |
| 2014-12-01 to 2015-05-31 | 22,656 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | -12,203,424 | USD | 183 |
| 2014-12-01 to 2015-05-31 | -292,594 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | 34,716 | USD | 183 |
| 2014-12-01 to 2015-05-31 | -103,253 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-05-31 | 4,258,281 | USD | 183 |
| 2014-12-01 to 2015-05-31 | -7,225 | USD | 182 |
Inspect the source
- Entity
- CHINA GEWANG BIOTECHNOLOGY, INC. / CIK 0001489902
- Captured
- SEC response SHA-256
22d1ada7cabb107cd5c87bbc68f28532c205fa36102df7e559bb894b418b9840
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001489902.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))